- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Industry News: iCAD shows expanded CAD portfolio
Computer aided detection remains the core focus of iCAD, but the company, once known only for its mammography products, has a much broader portfolio these days.
Computer aided detection remains the core focus of iCAD, but the company, once known only for its mammography products, has a much broader portfolio these days. At ECR 2009, iCAD demonstrated its virtual colonoscopy product, VeraLook, CAD software designed to detect polyps in 3D reconstructions coming from CT scans. Following the usual approach, CAD algorithms tag suspicious findings that deserve a closer look from radiologists. Software packages for processing MR data of the breast and prostate were also shown.
True to its roots in mammography, iCAD demonstrated elements of its next generation SecondLook Digital CAD now in development, ones that promise improved performance, including “lesion metrics” that further document CAD findings. Current versions of the company’s software is approved and shipping with GE and Fuji full field digital mammography systems. Ones customized for Agfa, Sectra, Philips and Planmed were also in the iCAD booth at ECR.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).
